These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2214176)

  • 1. [Complete remission in multiple myeloma with natural interferon-alpha (HLBI) and melphalan/prednisolone intermittent therapy].
    Ito M; Nakagawa T; Imoto S; Isobe T; Nakao Y
    Rinsho Ketsueki; 1990 Jun; 31(6):847-52. PubMed ID: 2214176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI), melphalan and prednisolone (HLBI-MP) in multiple myeloma].
    Hara M; Nakamura T; Fujii Y
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1338-41. PubMed ID: 3579331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonproducing myeloma without evident bone lesion].
    Kawatani T; Maeda N; Hosoda A; Agou H; Nakai K; Kawasaki H
    Rinsho Ketsueki; 1990 Jun; 31(6):842-6. PubMed ID: 2214175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of M2-protocol and interferon-alpha as remission induction in refractory multiple myeloma.
    Shimamoto Y; Matsuzaki M; Ono K; Sano M; Yamaguchi M
    Haematologia (Budap); 1991; 24(1):9-11. PubMed ID: 1813363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI) and methyl-prednisolone (HLBI-mP) in multiple myeloma].
    Fukuzawa Y; Kawamura T; Ohno R
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3581-6. PubMed ID: 2817909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New protocols for myeloma chemotherapy plus IFN alpha].
    Kitani T
    Rinsho Ketsueki; 1993 Apr; 34(4):455-9. PubMed ID: 8510333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the therapy of multiple myelomas--initial induction therapy (MP, IFN alpha, steroid pulse) and maintenance therapy (VMP, MP continuous, VEP, MCNU)].
    Tanaka H; Kawano M; Iwato K; Asaoku H; Tanabe O; Ishikawa H; Nobuyoshi M; Sakai A; Kuramoto A
    Rinsho Ketsueki; 1992 May; 33(5):655-61. PubMed ID: 1630017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type].
    Suzuki A; Iwase O; Ohkubo T; Nakano M; Toyama K
    Rinsho Ketsueki; 1991 Jan; 32(1):47-51. PubMed ID: 1902271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.
    Ahre A; Björkholm M; Mellstedt H; Brenning G; Engstedt L; Gahrton G; Gyllenhammar H; Holm G; Johansson B; Järnmark M
    Cancer Treat Rep; 1984 Nov; 68(11):1331-8. PubMed ID: 6388832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum beta-2-microglobulin in patients with multiple myeloma treated with alpha interferon.
    Murakami H; Ogawara H; Morita K; Saitoh T; Matsushima T; Tamura J; Sawamura M; Karasawa M; Miyawaki S; Schimano S; Satoh S; Tsuchiya J
    J Med; 1997; 28(5-6):311-8. PubMed ID: 9604789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the treatment of multiple myeloma].
    Wada M; Mizoguchi H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoparathyroidism during alpha-INF therapy in a patient with multiple myeloma.
    Ueki K; Tsuchida A; Murakami H; Yano S; Kobayashi N; Omine M; Naruse T
    J Med; 1989; 20(5-6):391-7. PubMed ID: 2628520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IgA-lambda type myeloma complicating with autoimmune hemolytic anemia].
    Nakase T; Morita K; Tomeoku M; Katou M; Kanamaru M; Shirakawa S
    Rinsho Ketsueki; 1990 Dec; 31(12):1967-8. PubMed ID: 2127809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complete remission of plasmablastic IgD lambda multiple myeloma induced by continuous infusion of low-dose cytarabine and etoposide].
    Fukuno K; Tsurumi H; Yamada T; Oyama M; Moriwaki H
    Rinsho Ketsueki; 2000 Jun; 41(6):513-8. PubMed ID: 10921352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment.
    Powles R; Raje N; Milan S; Millar B; Shepherd V; Mehta J; Singhal S; Kulkarni S; Viner C; Gore M; Cunningham D; Treleaven J
    Bone Marrow Transplant; 1997 Sep; 20(6):435-43. PubMed ID: 9313875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
    Shindo T; Yumoto Y; Yoshida M; Okuda T
    Rinsho Ketsueki; 2002 Feb; 43(2):107-11. PubMed ID: 11925872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of gastric amyloidosis developing into Bence-Jones type multiple myeloma, treated effectively by cyclo-VAMP chemotherapy].
    Ayabe T; Maekawa I; Ashida T; Taruishi M; Shibata Y; Namiki M
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2399-403. PubMed ID: 8259860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rapid growth of glioblastoma during therapy for multiple myeloma: case report].
    Sonoda Y; Kumabe T; Umezawa K; Shimizu H; Murakawa Y; Kanamaru R; Yoshimoto T
    No Shinkei Geka; 1998 Aug; 26(8):737-41. PubMed ID: 9744004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of aggressive multiple myeloma].
    Oda Y; Ooi S; Endoh A; Urushidani Y; Nakamura R; Adachi K
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):489-92. PubMed ID: 21403462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.